Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Apr 30, 2024 7:56pm
61 Views
Post# 36016220

RE:RE:RE:RE:Why is everyone so obsessed with PR?

RE:RE:RE:RE:Why is everyone so obsessed with PR?
Starkicker wrote: LABS did benefit from hype in 2018 when the SP was driven up to $7.34. But to be fair, that was when everybody was throwing all their money at any pot stock they could find. Investors are more wary these days, especially for an 8 cent stock. I'll ask this, though... if the big boys aren't showing up until the mid-$1s, whose going to get it there?


Nah, it wasn't hype that took it to $7.  Back then, the revs were stratospheric and $7 was fair.  If LABS traded on hype, they would have been to $50 and beyond like CGC, and probably would have had the no name business not imploded so soon.

Big boys will come in before mid $1s, they just won't announce that they are.  BNN interviews isn't the answer.  Pidduck golfing and lunching with certain types is.
<< Previous
Bullboard Posts
Next >>